Cliff Asness’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$722K Sell
9,868
-4,287
-30% -$295K ﹤0.01% 3192
2026
Q1
$905K Buy
14,155
+148
+1% +$10.3K ﹤0.01% 2824
2025
Q4
$1.11M Buy
14,007
+29
+0.2% +$2.45K ﹤0.01% 2487
2025
Q3
$924K Buy
13,978
+329
+2% +$19.6K ﹤0.01% 2481
2025
Q2
$723K Buy
+13,649
New +$641K ﹤0.01% 2401
2022
Q1
Sell
-422
Closed -$37K 2250
2021
Q4
$37K Hold
422
﹤0.01% 2184
2021
Q3
$51K Buy
+422
New +$57.7K ﹤0.01% 2225

Other funds holding IRON

Cliff Asness's IRON Position: Q2 2026 in Review

Cliff Asness reduced its Disc Medicine (IRON) stake by 30% in Q2 2026, selling an estimated $295K and leaving 9,868 shares worth $722K. The position accounts for ﹤0.01% of the portfolio, ranked #3192.

Cliff Asness first reported a position in IRON in Q3 2021 and has held it in 7 quarters since. The position peaked at $1.11M in Q4 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Cliff Asness held 9,868 shares of Disc Medicine worth $722K as of Q2 2026.
  • Cliff Asness sold 4,287 Disc Medicine shares in Q2 2026, an estimated $295K.
  • Disc Medicine made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3192 holding.
  • Cliff Asness first reported a position in Disc Medicine in Q3 2021 and has held it in 7 quarters since.
  • Cliff Asness's Disc Medicine position peaked at $1.11M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.